News
FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical ...
1d
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
1d
NewsNation on MSNMAHA report is call to look at root causes of disease: FDA commissionerFDA Commissioner Dr. Marty Makary said Thursday that the United States needs to transform its health care approach from ...
Food and Drug Administration Commissioner Marty Makary testified May 22 before the Senate Appropriations Subcommittee on ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
FDA Commissioner Dr. Marty Makary joins host Blake Burman to discuss the Trump administration's newly released "Make America Healthy Again" (MAHA) report. Makary asserts that the campaign's goal is to ...
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results